Covista Inc.
CVSA · Services-Educational Services · 34.0M shares · -6%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: $109M (gross $123M, SBC $14M)
Reference price $130.78 · est. market cap ~$4.5B — last insider sale, 2026-06-11 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
B80gen composite 73pct→80
Notable findings
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Weak liquidityCurrent ratio 0.82 (<1)
- Buying back stockNet buyback — share count -6%/yr over 4y
- Strong balance sheetStrong balance sheet — $200M cash & investments
- Notable holderHeld by 6 notable fund(s): FMR LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +3 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
56.9%
Operating margin
19.1%
Net margin
13.3%
Return on equity
16.5%
Return on assets
8.6%
ROIC
13.6%
Revenue growth (QoQ)
4.5%
Net-income growth
73.3%
Debt / equity
0.4×
Interest coverage
6.5×
Current ratio
0.8×
Free cash flow
$288M
Tangible book value
-$293M
Cash & investments
$200M
Stock comp / revenue
2.3%
Leadership & compensation
| Name | Role | Latest total comp |
|---|---|---|
| Beard, Stephen W. | Chairman & CEO | — |
| BECK DOUGLAS G. | SVP, GC, Corp. Sec & ISS | — |
| Betz Michael | Pres. Walden University & CDO | — |
| Cox Karen Sue | President, Chamberlain Univ. | — |
| Gangadharan Manjunath | VP, Chief Accounting Officer | — |
| Herrera Maurice | SVP - Chief Marketing Officer | — |
| Hill Sara | CHRO | — |
| Liles Scott | President, Medical and Vet | — |
| Noel Megan | Chief Corp. Affairs Officer | — |
| Phelan Robert J. | Chief Financial Officer | — |
| Trent Evan | President, Adtalem Elevate | — |
| BURKE WILLIAM W | Director | — |
| Hrinak Donna J | Director | — |
| Kiser Georgette D. | Director | — |
| Krehbiel William V | Director | — |
| MALAFRONTE MICHAEL W | Director | — |
| O'KEEFE SHARON | Director | — |
| Phelan Kenneth J | Director | — |
| Vandenbosch Betty M. | Director | — |
| WARDELL LISA W | Director | — |
Officers & directors from SEC filings (Form 4 + DEF 14A proxy); compensation is the latest reported fiscal year.
Insider transactions · last 6 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-11 | Beard, Stephen W. | Sell | 2.5K | $130.78 |
| 2026-06-10 | Beard, Stephen W. | Sell | 2.8K | $130.14 |
| 2026-05-18 | Gangadharan Manjunath | Tax withheld | 426 | $127.85 |
| 2026-05-08 | Cox Karen Sue | Sell | 2.0K | $124.50 |
| 2026-05-08 | Beard, Stephen W. | Sell | 16K | $131.25 |
| 2026-05-08 | Phelan Robert J. | Sell | 10K | $126.21 |
| 2026-05-08 | BECK DOUGLAS G. | Sell | 9.6K | $127.03 |
| 2026-04-15 | Liles Scott | Tax withheld | 448 | $112.49 |
| 2026-03-11 | MALAFRONTE MICHAEL W | Buy | 8.9K | $100.94 |
| 2026-03-10 | MALAFRONTE MICHAEL W | Buy | 12K | $100.86 |
| 2026-03-10 | MALAFRONTE MICHAEL W | Buy | 15K | $100.86 |
| 2026-03-03 | MALAFRONTE MICHAEL W | Buy | 1.2K | $97.97 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-07 | ResultsExhibits | filing ↗ |
| 2026-04-09 | Reg FDExhibits | filing ↗ |
| 2026-03-03 | Material agreement1.02Debt obligationExhibits | filing ↗ |
| 2026-02-24 | Reg FDExhibits | filing ↗ |
| 2026-02-06 | 5.03Reg FDExhibits | filing ↗ |
| 2026-01-28 | ResultsExhibits | filing ↗ |
| 2025-12-15 | OtherExhibits | filing ↗ |
| 2025-11-14 | Shareholder vote | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-07 | 2026-05-07 | 0000730464-26-000021 ↗ |
| 10-Q | 2026-05-07 | 2026-03-31 | 0001104659-26-057163 ↗ |
| 8-K | 2026-04-09 | 2026-04-09 | 0000730464-26-000015 ↗ |
| 8-K | 2026-03-03 | 2026-03-02 | 0000730464-26-000010 ↗ |
| 8-K | 2026-02-24 | 2026-02-24 | 0000730464-26-000007 ↗ |
| 8-K | 2026-02-06 | 2026-02-05 | 0001104659-26-011611 ↗ |
| 8-K | 2026-01-28 | 2026-01-28 | 0000730464-26-000003 ↗ |
| 10-Q | 2026-01-28 | 2025-12-31 | 0001104659-26-007415 ↗ |
| 8-K | 2025-12-15 | 2025-12-15 | 0000730464-25-000063 ↗ |
| 8-K | 2025-11-14 | 2025-11-12 | 0000730464-25-000060 ↗ |
| 10-Q | 2025-10-30 | 2025-09-30 | 0001104659-25-104397 ↗ |
| 8-K | 2025-10-30 | 2025-10-30 | 0000730464-25-000033 ↗ |